Akzo Nobel N.V. (AKZA.AS) is preparing for its earnings announcement on April 22, 2026. The Dutch specialty chemicals and coatings giant trades at €53.30 per share with a market cap of €9.3 billion. While specific earnings estimates remain unavailable, investors are watching closely as the company navigates a challenging market environment. Akzo Nobel’s trailing twelve-month EPS stands at €3.70, reflecting the company’s profitability amid industry headwinds. The stock has gained 1.41% recently, suggesting cautious optimism ahead of the earnings release. Meyka AI rates AKZA.AS with a grade of B+, indicating neutral positioning with mixed fundamental signals.
Stock Performance and Valuation Metrics
Akzo Nobel’s stock has shown mixed momentum in recent trading sessions. The company’s current valuation appears reasonable relative to its earnings power.
Current Trading Levels
AKZA.AS trades at €53.30, up €0.74 or 1.41% in recent sessions. The stock sits between its 52-week low of €46.18 and high of €62.74. Trading volume reached 522,758 shares, above the average of 720,413, indicating moderate investor interest ahead of earnings. The stock’s year-to-date performance shows a decline of 8.11%, reflecting broader market pressures on the chemicals sector.
Valuation Assessment
The company trades at a P/E ratio of 14.7x trailing earnings, below the historical average. Price-to-sales ratio stands at 0.92x, suggesting the market values Akzo Nobel’s revenue generation efficiently. The dividend yield of 3.64% provides income support for shareholders. Book value per share is €28.18, with the stock trading at 2.0x book value, indicating moderate premium pricing relative to net assets.
Technical Positioning
Technical indicators show mixed signals. The RSI of 58.73 suggests neutral momentum, neither overbought nor oversold. The Stochastic indicator at 82.96 points to potential overbought conditions. MACD remains negative at -0.23, though the histogram shows positive divergence. The ADX reading of 29.35 confirms a strong underlying trend in the market.
Financial Health and Operational Efficiency
Akzo Nobel demonstrates solid operational fundamentals despite recent market challenges. The company maintains adequate liquidity and manages its debt responsibly.
Profitability Margins
Gross profit margin stands at 39.86%, reflecting the company’s pricing power in specialty coatings. Operating margin of 7.62% shows efficiency in core operations. Net profit margin of 6.25% indicates that roughly six cents of every euro in sales converts to profit. Return on equity of 14.61% demonstrates reasonable returns on shareholder capital. Return on assets of 4.55% reflects moderate asset utilization across the global operations.
Cash Flow Generation
Operating cash flow per share reaches €5.35, while free cash flow per share stands at €3.54. The company generates sufficient cash to fund operations and shareholder returns. Operating cash flow to sales ratio of 9.01% shows healthy conversion of earnings to actual cash. However, free cash flow declined 56.31% year-over-year, signaling pressure on capital deployment and investment capacity.
Balance Sheet Strength
Current ratio of 1.44x indicates adequate short-term liquidity. Debt-to-equity ratio of 1.04x shows moderate leverage. Interest coverage of 4.16x provides comfortable debt servicing capacity. Working capital of €1.85 billion supports operational needs. The company maintains €11.22 per share in cash, providing financial flexibility for strategic initiatives.
Growth Trends and Market Outlook
Recent financial growth shows mixed signals, with earnings expansion offset by operational challenges. The company faces headwinds in cash generation despite revenue stability.
Recent Growth Performance
Revenue growth of 0.40% year-over-year reflects stagnation in top-line expansion. Gross profit grew 2.43%, outpacing revenue growth and showing margin improvement. However, operating income declined 10.88%, indicating rising operational costs. Net income grew 22.62%, boosted by favorable tax items and lower interest expenses. EPS growth of 22.39% significantly outpaced net income growth due to share buybacks.
Multi-Year Trends
Five-year revenue growth per share reached 44.11%, demonstrating long-term expansion. Three-year revenue growth of 21.04% shows sustained top-line progress. However, three-year net income growth declined 29.17%, indicating margin compression. Dividend per share grew 12.16% year-over-year, reflecting management confidence in cash generation despite operational challenges.
Forward Outlook
Price forecasts suggest caution. The yearly forecast of €52.96 implies modest downside from current levels. Three-year forecast of €43.38 indicates potential 18.6% decline. Five-year forecast of €33.70 suggests significant long-term pressure. These forecasts reflect concerns about the specialty chemicals sector’s structural challenges and competitive pressures.
Meyka AI Analysis and Investment Perspective
Meyka AI rates AKZA.AS with a B+ grade, reflecting balanced but cautious positioning. The rating incorporates multiple fundamental and technical factors.
Rating Breakdown
The B+ grade scores 74.94 out of 100, suggesting neutral recommendation. DCF valuation scores 5/5 (Strong Buy), indicating intrinsic value support. ROE scores 4/5 (Buy), showing reasonable returns on equity. ROA scores 5/5 (Strong Buy), reflecting efficient asset deployment. However, debt-to-equity scores 1/5 (Strong Sell), highlighting leverage concerns. P/E ratio scores 2/5 (Sell), suggesting the stock may not offer compelling value at current multiples.
Key Strengths
The company benefits from strong brand portfolio including Dulux, International, Sikkens, and Interpon. Global distribution network spans 130+ countries. Specialty coatings business provides higher margins than commodity products. Dividend yield of 3.64% offers income support. Reasonable P/E of 14.7x provides valuation cushion.
Key Concerns
Free cash flow declined sharply 56.31% year-over-year, limiting capital flexibility. Operating income fell 10.88%, indicating cost pressures. Debt-to-equity of 1.04x remains elevated for a cyclical business. Three-year net income declined 29.17%, showing margin compression. Price forecasts suggest 18-36% downside over medium term.
Final Thoughts
Akzo Nobel N.V. approaches its April 22 earnings announcement with mixed fundamentals. The company maintains solid profitability with 14.7x P/E valuation and 3.64% dividend yield, supported by Meyka AI’s B+ rating. However, concerning trends include 56% free cash flow decline, 10.88% operating income drop, and weak price forecasts suggesting 18-36% downside. Revenue growth stalled at 0.40%, though EPS expanded 22.39% via buybacks. The specialty chemicals sector faces structural headwinds. Investors should await earnings details on forward guidance and cash flow recovery before making decisions. Current valuation offers modest support, but operational momentum remains questionable.
FAQs
What is Akzo Nobel’s current stock price and valuation?
AKZA.AS trades at €53.30 with a P/E ratio of 14.7x and price-to-sales of 0.92x. Market cap is €9.3 billion. The dividend yield is 3.64%. Valuation appears reasonable but forecasts suggest potential downside risk ahead.
How did Akzo Nobel’s earnings grow recently?
EPS grew 22.39% year-over-year, but net income only grew 22.62%. Revenue stalled at 0.40% growth. Operating income fell 10.88%, indicating cost pressures. Free cash flow declined 56.31%, a major concern for capital allocation and shareholder returns.
What is Meyka AI’s rating for AKZA.AS?
Meyka AI rates AKZA.AS with a B+ grade (74.94/100), suggesting neutral positioning. DCF and ROA metrics score strong, but debt-to-equity and P/E ratios score weak. The rating reflects balanced but cautious outlook on the stock.
What are the main risks for Akzo Nobel investors?
Key risks include 56% free cash flow decline, 10.88% operating income drop, and elevated debt-to-equity of 1.04x. Price forecasts suggest 18-36% downside. Specialty chemicals sector faces structural headwinds and competitive pressures affecting margins.
When is Akzo Nobel’s earnings announcement?
Akzo Nobel reports earnings on April 22, 2026 at 15:30 UTC. Investors should monitor the announcement for forward guidance, cash flow trends, and management commentary on market conditions and cost pressures.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)